NYSE:IVC - Invacare Stock Price, Forecast & News

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Invacare announced a quarterly dividend on Thursday, November 21st. Shareholders of record on Friday, January 3rd will be given a dividend of $0.0125 per share on Friday, January 17th. This represents a $0.05 annualized dividend and a yield of 0.55%. The ex-dividend date of this dividend is Thursday, January 2nd. View Invacare's Dividend History.

Invacare Co. (NYSE:IVC) posted its earnings results on Wednesday, November, 6th. The health services provider reported ($0.15) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.20) by $0.05. The health services provider earned $235.80 million during the quarter, compared to analysts' expectations of $244.81 million. Invacare had a negative net margin of 3.82% and a negative return on equity of 9.30%. The company's revenue was down 3.6% compared to the same quarter last year. During the same period last year, the firm posted ($0.40) earnings per share. View Invacare's Earnings History.

Invacare is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Invacare.

1 analysts have issued twelve-month target prices for Invacare's shares. Their forecasts range from $15.00 to $15.00. On average, they expect Invacare's share price to reach $15.00 in the next twelve months. This suggests a possible upside of 65.0% from the stock's current price. View Analyst Price Targets for Invacare.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Invacare.

News headlines about IVC stock have been trending extremely negative on Wednesday, InfoTrie reports. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Invacare earned a daily sentiment score of -4.2 on InfoTrie's scale. They also assigned press coverage about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Invacare.

Some companies that are related to Invacare include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include ImmunoGen (IMGN), Opko Health (OPK), ResMed (RMD), Catalyst Pharmaceuticals (CPRX), Immunomedics (IMMU), Lexicon Pharmaceuticals (LXRX), TherapeuticsMD (TXMD), Chesapeake Energy (CHK), NovaBay Pharmaceuticals (NBY) and Abeona Therapeutics (ABEO).

Invacare's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Millennium Management LLC (7.54%), Krensavage Asset Management LLC (3.64%), State Street Corp (3.38%), Granahan Investment Management Inc. MA (1.68%), Keeley Teton Advisors LLC (0.92%) and Stephens Inc. AR (0.87%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dean J Childers, Kathleen P Leneghan and Matthew E Monaghan. View Institutional Ownership Trends for Invacare.

IVC stock was sold by a variety of institutional investors in the last quarter, including Krensavage Asset Management LLC, Squarepoint Ops LLC, Keeley Teton Advisors LLC, Essex Investment Management Co. LLC, Granahan Investment Management Inc. MA, Adirondack Research & Management Inc. and Nisa Investment Advisors LLC. View Insider Buying and Selling for Invacare.

IVC stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Stephens Inc. AR, Mackay Shields LLC, Dupont Capital Management Corp, Voya Investment Management LLC, BBVA USA Bancshares Inc., State Street Corp and State of Alaska Department of Revenue. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan. View Insider Buying and Selling for Invacare.

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IVC stock can currently be purchased for approximately $9.09.

Invacare has a market capitalization of $305.94 million and generates $972.35 million in revenue each year. The health services provider earns $-43,920,000.00 in net income (profit) each year or ($1.32) on an earnings per share basis. Invacare employs 4,200 workers across the globe.View Additional Information About Invacare.

The official website for Invacare is http://www.invacare.com/.

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]